2022-12-15 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 20,000 0.0062% | $15.88 | $317,600 | +23.01% | |
2021-12-15 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 47,500 0.0146% | $17.44 | $828,400 | +5.26% | |
2021-11-15 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 47,500 0.015% | $18.09 | $859,275 | +4.04% | |
2021-10-15 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 47,500 0.015% | $21.92 | $1.04M | -12.24% | |
2021-09-15 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 47,500 0.0151% | $20.46 | $971,850 | -4.35% | |
2021-08-16 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 55,000 0.0174% | $18.44 | $1.01M | +7.73% | |
2021-07-15 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 60,000 0.0191% | $17.47 | $1.05M | +11.17% | |
2021-06-17 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 60,000 0.0191% | $22.18 | $1.33M | -13.96% | |
2021-04-01 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 60,000 0.0191% | $22.96 | $1.38M | -14.49% | |
2021-03-01 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 65,000 0.0206% | $22.11 | $1.44M | -11.35% | |
2021-02-01 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 65,000 0.0207% | $22.08 | $1.44M | -6.84% | |
2021-01-04 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 65,000 0.0206% | $20.32 | $1.32M | +5.02% | |
2020-12-18 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 65,000 0.021% | $20.01 | $1.3M | +8.37% | |
2020-06-08 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 26,000 0.0084% | $22.56 | $586,560 | +0.29% | |
2020-05-07 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 50,000 0.0164% | $25.54 | $1.28M | -9.82% | |
2020-04-06 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 50,000 0.0159% | $17.26 | $863,000 | +27.96% | |
2019-06-18 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 100,000 0.0329% | $20.67 | $2.07M | -7.27% | |
2019-06-17 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 117,404 0.0386% | $20.53 | $2.41M | -6.78% | |
2019-06-13 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 27,596 0.0092% | $20.03 | $552,748 | -3.31% | |
2017-03-01 | Sale | Exelixis, Inc. EXEL | EVP, Scientific Strategy & CSO | 45,000 0.0157% | $22.19 | $998,550 | +18.79% |